AAA
MGNX icon

Affinity Asset Advisors’s MacroGenics MGNX Stock Holding History

Affinity Asset Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.62M Buy
1,216,606
+716,606
+143% +$2.71M 0.25% 74
2026
Q1 		$1.45M Buy
500,000
+15,692
+3% +$33.5K 0.07% 97
2025
Q4 		$780K Buy
+484,308
New +$761K 0.04% 89
2021
Q3 		– Sell
-80,000
Closed -$2.15M – 85
2021
Q2 		$2.15M Buy
80,000
+55,000
+220% +$1.61M 0.77% 32
2021
Q1 		$796K Buy
+25,000
New +$607K 0.27% 53

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Affinity Asset Advisors's MGNX Position: Q2 2026 in Review

Affinity Asset Advisors increased its MacroGenics (MGNX) stake by 143% in Q2 2026, buying an estimated $2.71M and bringing the position to 1,216,606 shares worth $5.62M. The position accounts for 0.25% of the portfolio, ranked #74.

Affinity Asset Advisors first reported a position in MGNX in Q1 2021 and has held it in 5 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Affinity Asset Advisors held 1,216,606 shares of MacroGenics worth $5.62M as of Q2 2026.
  • Affinity Asset Advisors bought 716,606 MacroGenics shares in Q2 2026, an estimated $2.71M.
  • MacroGenics made up 0.25% of Affinity Asset Advisors's portfolio in Q2 2026, its #74 holding.
  • Affinity Asset Advisors first reported a position in MacroGenics in Q1 2021 and has held it in 5 quarters since.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Affinity Asset Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.